US Patent Issued to SHANGHAI EAST HOSPITAL (EAST HOSPITAL, TONGJI UNIVERSITY SCHOOL OF MEDICINE) on April 7 for "Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,261, issued on April 7, was assigned to SHANGHAI EAST HOSPITAL (EAST HOSPITAL, TONGJI UNIVERSITY SCHOOL OF MEDICINE) (Shanghai).

"Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases" was invented by Yihan Chen (Shanghai), Dandan Liang (Shanghai), Yi Liu (Shanghai), Subas Man Sakya (Shanghai), Li Li (Shanghai), Fulei Zhang (Shanghai), Huixing Zhou (Shanghai) and Xiaoyu He (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is the use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases. Specifically, disclosed is the use of comp...